Palisade BioPALI
13F holders, Q2 2025 (June 30)11holders −2
3new positions
5sold out
$0.68avg. 13F price*
At the end of Q2 2025, 11 institutions reported holding Palisade Bio Inc. (PALI) in their 13F filings, down 2 from Q1 2025. 3 opened new positions and 5 sold out. The largest holders were XTX Topco Ltd ($19K), Geode Capital Management, LLC ($17K) and Two Sigma Securities, LLC ($11K).
- Company
- Palisade Bio Inc.
- CUSIP
- 696389402
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $26K |
| Exits | 5 | $145K |
All 13F filers, Q1 2025 → Q2 2025: 40,675 shares bought and 252,423 shares sold, net −211,748 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| XTX Topco Ltd | 0.00% | New | 27,337 | $19K |
| Geode Capital Management, LLC | 0.00% | No change | 24,732 | $17K |
| Two Sigma Securities, LLC | 0.00% | Add +12.8% | 15,969 | $11K |
| NFSG Corp | 0.00% | New | 10,500 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.1% | 4,567 | $3K |
| Transce3nd, LLC | 0.00% | New | 1,000 | $680 |
| UBS Group AG | 0.00% | Reduce -99.1% | 332 | $226 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 100 | $68 |
| Bank of America Corp. | 0.00% | Add +95.7% | 45 | $31 |
| Wells Fargo & Company | 0.00% | No change | 21 | $14 |
| Morgan Stanley | 0.00% | Reduce -98.9% | 7 | $5 |
"% of holder's portfolio" is PALI's weight in each manager's 13F, not the share of Palisade Bio Inc. the manager owns.